Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Kendle International Inc. (NasdaqNM:KNDL)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Financials
Recent Events
Aug  7Price hit new 52-week high ($21.35)
Location
441 Vine Street, Suite 1200
Cincinnati, OH 45202
Phone: (513) 381-5550
Fax: (513) 562-1789
Email: info@kendle.com
Employees (last reported count): 1,500
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Investor Relations
 ·Employment
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 74%
·Over the last 6 months:
 · 2 insider sells; 79.0K shares
  (0.9% of insider shares)
·Institutional: 66% (256% of float)
(82 institutions)
·Net Inst. Buying: 820.0K shares (+9.09%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Kendle International Inc. is a contract research organization that provides a broad range of Phase I through IV clinical research and drug development services to the pharmaceutical and biotechnology industries. The Company augments the research and development activities of pharmaceutical and biotechnology companies by offering value-added clinical research services and proprietary information technology designed to reduce drug development time and expense. The Company is organized into two segments for financial reporting purposes. The contract research services group conducts clinical trial management, clinical data management, statistical analysis, medical writing and regulatory consulting and representation. The medical communications group, Health Care Communications Inc., a wholly owned subsidiary of the Company, provides organizational, meeting management and publication services to professional associations and pharmaceutical companies.
More from Market Guide: Expanded Business Description

Financial Summary
Kendle International Inc. is a contract research organization providing integrated clinical research services on a contract basis to the pharmaceutical and biotechnology industries. For the six months ended 6/30/01, revenues increased 10% to $70.9 million. Net income totalled $1.1 million vs. a loss of $920 thousand. Revenues reflect growth from acquisitions. Earnings reflect the absence of employee severance expenses.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

Candace Kendle, 54
CEO, Chairman
$246K
Christopher Bergen, 50
Pres, COO, Director
229K
Timothy Mooney, 53
Exec. VP, CFO, Treasurer, Director
188K
Thomas Stilgenbauer, 53
Exec. VP and Chief Marketing Offficer
185K
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:KNDLAs of 31-Aug-2001
Price and Volume
52-Week Low
on 13-Oct-2000
$8.00 
Recent Price$20.36 
52-Week High
on 7-Aug-2001
$21.35 
Beta0.65 
Daily Volume (3-month avg)68.3K
Daily Volume (10-day avg)70.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y]
52-Week Change+133.5%
52-Week Change
relative to S&P500
+213.3%
Share-Related Items
Market Capitalization$251.4M
Shares Outstanding12.3M
Float3.20M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$11.22 
Earnings (ttm)-$0.01 
Earnings (mrq)$0.07 
Sales (ttm)$10.40 
Cash (mrq)$2.11 
Valuation Ratios
Price/Book (mrq)1.81 
Price/EarningsN/A 
Price/Sales (ttm)1.96 
Income Statements
Sales (ttm)$127.1M
EBITDA (ttm)$9.01M
Income available to common (ttm)-$70.0K
Profitability
Profit Margin (ttm)-0.1%
Operating Margin (ttm)-0.1%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-0.04%
Return on Equity (ttm)-0.05%
Financial Strength
Current Ratio (mrq)1.65 
Debt/Equity (mrq)0.12 
Total Cash (mrq)$25.9M
Short Interest
As of 8-Aug-2001
Shares Short545.0K
Percent of Float17.0%
Shares Short
(Prior Month)
524.0K
Short Ratio5.86 
Daily Volume93.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.